Global Capability Centers

Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence

As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability Centers (GCCs) have emerged as a transformative solution. Our latest whitepaper, "Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence," explores how GCCs—especially those based in India—are reshaping how the industry manages scientific…...
Read More

Top Stories

NASSCOM GCC Summit 2025

What’s Next for Global Capability Centers )?

The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
HEOR Pharma Payers

Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements

HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...

Medical Information in the Digital Age – Quick and Efficient Meets Responsive and Responsible

Medical Information (MI teams across the pharmaceutical industry respond to product-related medical queries from HCPs...
man reviewing clinical data, current treatments, economic data, product information, and data on burden of disease

HEOR in 2022: The Importance of Data Visualization, RWD, and Interactive Formats

Effectively communicating data in the pharmaceutical and medical community is vital to payer engagement. Learn...
How can pharma use bite-sized content to its benefit

Bite-Sized Content Helps Avoid User Fatigue – How Can Pharma Use It?

Today's readers tend to avoid long pharma content and medical jargon. If you want to...
Image - What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better

What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better?

While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the...
Image - Effectiveness of Artificial Intelligence–Powered Translation Tools in Developing Medical Publications An Assessment of Japanese-to-English Translation

Effectiveness of Artificial Intelligence-Powered Translation Tools in Developing Medical Publications: An Assessment of Japanese-to-English Translation

Artificial intelligence (AI)–powered translation tools are gaining attention and acceptance to increase efficiency in medical...

Learn more ABOUT our company.